Works matching IS 1662811X AND DT 2022 AND VI 14 AND IP 3


Results: 8
    1
    2
    3
    4

    ESCAPE: An Open-Label Trial of Personalized Immunotherapy in Critically lll COVID-19 Patients.

    Published in:
    Journal of Innate Immunity, 2022, v. 14, n. 3, p. 218, doi. 10.1159/000519090
    By:
    • Karakike, Eleni;
    • Dalekos, George N.;
    • Koutsodimitropoulos, Ioannis;
    • Saridaki, Maria;
    • Pourzitaki, Chryssa;
    • Papathanakos, Georgios;
    • Kotsaki, Antigone;
    • Chalvatzis, Stamatios;
    • Dimakopoulou, Vasiliki;
    • Vechlidis, Nikolaos;
    • Paramythiotou, Elisabeth;
    • Avgoustou, Christina;
    • Ioakeimidou, Aikaterini;
    • Kouriannidi, Elli;
    • Komnos, Apostolos;
    • Neou, Evangelia;
    • Rovina, Nikoletta;
    • Stefanatou, Eleni;
    • Milionis, Haralampos;
    • Nikolaidis, George
    Publication type:
    Article
    5
    6
    7
    8